Monitoring Natural Killer Cell Function in Human Ovarian Cancer Cells of Ascitic Fluid

Vikash Kumar1, Asok Mukhopadhyay2

  • 1Stem Cell Biology Laboratory, National Institute of Immunology, New Delhi, India.

Bio-Protocol
|September 17, 2021
PubMed

Insights

This study details a new method to assess natural killer (NK) cell activity by measuring cytokine release and tumor cell death. This approach helps identify NK-cell sensitive tumors for improved cancer therapies.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • Natural killer (NK) cells are crucial innate immune effectors, mediating host defense through target cell lysis and cytokine secretion.
  • NK cell function is vital for managing viral infections and malignant diseases, particularly in targeting cells lacking MHC class I.
  • Current NK cell activity assays include 51Cr-release and flow cytometry, but novel methods are needed.

Purpose of the Study:

  • To establish a protocol for evaluating NK cell activation and function.
  • To quantify NK cell-mediated killing of ovarian cancer cells.
  • To differentiate between NK-cell sensitive and insensitive tumor cells.

Main Methods:

  • Assessing NK cell activation via Interleukin-10 (IL-10) and Interferon-gamma (IFNγ) release.
  • Enumerating dead ovarian cancer cells following co-culture with NK cells from healthy donors and patients.
  • Utilizing cells isolated from patient ascitic fluid for tumor cell enumeration.

Main Results:

  • The protocol successfully measures NK cell activation through cytokine detection (IL-10, IFNγ).
  • NK cell function is quantitatively assessed by enumerating dead tumor cells.
  • The method effectively distinguishes between tumor cells susceptible and resistant to NK cell-mediated lysis.

Conclusions:

  • This protocol provides a comprehensive method to study NK cell function in vitro.
  • It enables the assessment of NK cell activity in both healthy individuals and cancer patients.
  • This technique can aid in discovering new therapeutic strategies for malignancies by identifying NK-cell sensitive tumors.